SlideShare a Scribd company logo
COVID-19
Proactive testing to mitigate spread
Carl T. Bergstrom
Department of Biology
University of Washington
IPAM Workshop on Mathematical Models in Understanding COVID-19
Photo: Carl Bergstrom
Analytic approximations
Ted Bergstrom, UCSB
Haoran Li, UCSB
Stochastic network model
Ryan McGee, UW
with Ben Kerr, Omar Cornejo,
Mark Tanaka, Julian Homberger,
Hannah Williams, Alicia Zhou
Photo: Carl Bergstrom
Disclosures
I have a paid consulting relationship with
Color Genomics, and I will be talking about
some of that work today. I have no financial
interest in the production or sales of COVID
tests or treatments.
I do have vested interests in going places,
seeing people, working at the office, eating at
restaurants, drinking at the bar, playing sports,
hearing live music, sending my son to school,
sending my daughter to college, visiting
Europe, visiting anywhere else, and
photographing birds that can’t be bothered to
visit Seattle.
Photo: Carl Bergstrom
A vaccine is coming
But it won’t be a panacea—if it comes at all.
Photo: Carl Bergstrom
We need something else
Something nimble.
Photo: Carl Bergstrom
This is a talk about testing.
Photo: Carl Bergstrom
Four roles for Covid-19 testing
Individual diagnosis, clearance, surveillance, and mitigation.
1. Individual diagnosis
Symptomatic patients, for
treatment and peace of
mind.
High sensitivity and
specificity desired.
CC-BY-2.0 Lisa Helfert
Four roles for Covid-19 testing
Individual diagnosis, clearance, surveillance, and mitigation.
2. Clearance
Verify that patients and
practitioners are uninfected
prior to performing a
procedure.
Travel? Other activities?
High sensitivity needed.
Specificity less essential.
CC 59th Medical Wing
Four roles for Covid-19 testing
Individual diagnosis, clearance, surveillance, and mitigation.
3. Surveillance
Public health officials want
to track prevalence and
trajectory of pandemic.
Can correct for lower
sensitivity and (if common)
lower specificity.
Chen and Ngu 2020 ProPublica
Four roles for Covid-19 testing
Individual diagnosis, clearance, surveillance, and mitigation.
4. Mitigation
Find non-symptomatic
cases and isolate / trace as
a means of disease control.
Volume is more important
than sensitivity or
specificity.
Larremore et al. 2020 Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
Speed is critical in all cases.
1. Individual health.
Patients don’t want to
wait.
Treatments may depend
on diagnosis.
Helfert; 59th Med Wing; ProPublica; Larremore
3. Surveillance
Heath officials need the
latest information to make
good decisions.
4. Mitigation
Every day’s delay is an
extra day an infected
person is walking around
spreading disease.
2. Clearance
Tests should be point-of-
care to minimize chance of
becoming infectious after
sampling.
The CDC guidelines state that:
Testing of all students, faculty and staff for
Covid-19 before allowing campus entry (entry
testing) has not been systematically studied. It is
unknown if entry testing in IHEs provides any
additional reduction in person-to-person
transmission of the virus beyond what would be
expected with implementation of other infection
preventive measures (e.g., social distancing,
cloth face covering, hand washing, enhanced
cleaning and disinfection). Therefore, CDC does
not recommend entry testing of all returning
students, faculty, and staff.
The aim of proactive (mitigation) testing:
Reducing exposure-days
Latent Infectious
Time
Test
quarantine
Delay d
Infectious period C
Results
C # infectious days
n Testing periodicity
q False negative rate
d Delay for results
By what fraction does testing and isolation
reduce exposure days relative to no testing at all?
C # infectious days
n Testing periodicity
q False negative rate
d Delay for results
When testing periodicity is longer than
infectious period, individuals will only be
tested once while infectious.
true positive false negativetested not tested
Simplifies to
Expected
exposure days
When testing periodicity is shorter than
the infectious period, you get multiple
chances to catch an infection.
Where and
C # infectious days
n Testing periodicity
q False negative rate
d Delay for results
After a bit of algebra, you can still get a nice expression for the expected
exposure days.
But some symptomatic individuals can
self-isolate. We need to account for this.
Time
Latent Asymptomatic
Exposure days
u
Latent Pre-sympt. Symptomatic, non-isolating
Exposure days
(1-u)v
Latent Pre-sympt. Sympt. Self-isolating
Exposure days
(1-u)(1-v)
Compare infectious days with testing to
infectious days without.
Compare infectious days with testing to
infectious days without.
Asymptomatic or don’t isolate Self-isolate
Compare infectious days with testing to
infectious days without.
Asymptomatic or don’t isolate Self-isolate
Results
The real world is not so simple
• Disease dynamics
• Social network structure
• Heterogeneity of disease trajectory, infectivity, etc.
• Varying test sensitivity over time
• Non-compliance with testing and isolation
Photo: Carl Bergstrom
Ryan McGee’s SEIRS+ framework
Open source python-based stochastic SEIRS model with multi-level
network structure, network interventions (targeted testing, social
distance, contact tracing, isolation, etc.)
https://github.com/ryansmcgee/seirsplus
Stochastic disease dynamics
https://github.com/ryansmcgee/seirsplus
Testing, tracing, and isolation
https://github.com/ryansmcgee/seirsplus
Multi-level network structure
https://github.com/ryansmcgee/seirsplus
Individual heterogeneity
https://github.com/ryansmcgee/seirsplus
Test sensitivity
Kucirka et al. 2020 Ann. Int. Med.
https://github.com/ryansmcgee/seirsplus
Use case: workplace testing
https://www.color.com/covid-19-outbreak-model
Setting: workplaces of size 50-1000.
Intervention: self-administered workplace testing via nasal swab.
Network: single-layer FARZ network with 40% global transmission
Outcome measure: size of epidemic resulting from one introduction
Simulation trajectories
https://www.color.com/covid-19-outbreak-model
Most outbreaks fizzle
https://www.color.com/covid-19-outbreak-model
Testing helps
https://www.color.com/covid-19-outbreak-model
Testing helps a lot
https://www.color.com/covid-19-outbreak-model
Total epidemic size
Outbreak sizes
https://www.color.com/covid-19-outbreak-model
Mean fraction infected Fraction of introductions infecting >5%
Speed is of the essence
https://www.color.com/covid-19-outbreak-model
Mean fraction infected
Fraction >5%
Total epidemic size
Use case: community test-trace-isolate
Setting: Community of 50,000
Intervention: test-trace-isolate
Network: multilayer FARZ with household, school, workplace structure.
Outcome measure: change in effective R value
Test and isolate only
Test, trace, and isolate
Households of positive tests are isolated.
Contacts traced in two days, and isolated along with household.
Comparing with the analytic approximation
Comparing with the analytic approximation
Pooled testing stretches capacity.
Pooled testing stretches capacity.
Pooled testing stretches capacity.
Take-home messages
Proactive testing can help control the epidemic…
…but the speed of turnaround is essential.
Simple models give decent approximations and allow
quick exploration of speed / sensitivity / volume / cost tradeoffs.
Network structure and heterogeneity matter—especially for rapid spread.
Photo: Carl Bergstrom
http://ctbergstrom.com

More Related Content

PPTX
Initial Training Slides
PPTX
Multi Specialty Presentation
PPTX
Urology Presentation
PDF
B_Safe System v2
PDF
Thesis (J. Kyle Treman)
PPTX
Lessons from COVID19 for Future Pandemics - Dr Jay Varma.pptx
PDF
Safeguarding Health - The Synergy Of COVID-19 And Flu Rapid Testing
PPTX
Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...
Initial Training Slides
Multi Specialty Presentation
Urology Presentation
B_Safe System v2
Thesis (J. Kyle Treman)
Lessons from COVID19 for Future Pandemics - Dr Jay Varma.pptx
Safeguarding Health - The Synergy Of COVID-19 And Flu Rapid Testing
Mark Lipsitch: "Simulation and Deliberation to Prepare for Clinical Trials in...

Similar to Proactive COVID-19 testing to mitigate spread (20)

PDF
Viral Challenge Studies: An Innovative Way to Speed Up Vaccine Development; A...
 
PDF
Genomics in Public Health
PDF
Inovio jun13pres
PPTX
ImmunoScience Introduction
PDF
Coronavirus Pandemic Part III (A): Diagnostic Technologies
PDF
Diagnostic Testing Conference 2020
PPTX
07.31.20 | Vaccines for the Prevention of COVID-19: An Unprecedented Need – A...
PPTX
Epidemiology of Pandemics: How Mathematical Modeling Informs Public Health Po...
PPTX
Working the Science and Regulations Harder to Win Your Drug and Device Cases
PPTX
Analytical epidemiology
PDF
Inovio may13presentation
PDF
Covid19 Vaccines Where We Stand And Challenges Ahead Guido Forni
PPTX
2020.03.22-PartnerUpdateSlides.pptx
PPTX
presentation RTI.........................
PPTX
COVID 19_Vignesh.pptx
PPTX
Case Control Studies.pptx
PDF
Hiv Prevention A Comprehensive Approach 1st Edition Kenneth H Mayer
PPTX
Descriptive epidemiology
PDF
Vaccines myths and facts extended
PPTX
Epcm l9(new) screening for diseases
Viral Challenge Studies: An Innovative Way to Speed Up Vaccine Development; A...
 
Genomics in Public Health
Inovio jun13pres
ImmunoScience Introduction
Coronavirus Pandemic Part III (A): Diagnostic Technologies
Diagnostic Testing Conference 2020
07.31.20 | Vaccines for the Prevention of COVID-19: An Unprecedented Need – A...
Epidemiology of Pandemics: How Mathematical Modeling Informs Public Health Po...
Working the Science and Regulations Harder to Win Your Drug and Device Cases
Analytical epidemiology
Inovio may13presentation
Covid19 Vaccines Where We Stand And Challenges Ahead Guido Forni
2020.03.22-PartnerUpdateSlides.pptx
presentation RTI.........................
COVID 19_Vignesh.pptx
Case Control Studies.pptx
Hiv Prevention A Comprehensive Approach 1st Edition Kenneth H Mayer
Descriptive epidemiology
Vaccines myths and facts extended
Epcm l9(new) screening for diseases
Ad

More from Carl Bergstrom (12)

PPTX
The cost of acquiring information by natural selection
PDF
Transforming Science Education in An Age of Misinformation
PPTX
Peer Review Filters.pptx
PPTX
Burning Money: Competition Generates Massive Inefficiencies in the Grant Pr...
PPTX
Information Technology and the Ubiquity of Bullshit
PDF
Models of science
PDF
Information Concealing Games
PDF
Why scientists chase big problems (and why it matters)
PDF
Citation metrics and the stories they tell
PDF
It's all a game: The twin fallacies of epistemic purity and the scholarly inv...
PDF
Anthropogenic evolution, externalities, and public health
PDF
Navigating science using citation networks
The cost of acquiring information by natural selection
Transforming Science Education in An Age of Misinformation
Peer Review Filters.pptx
Burning Money: Competition Generates Massive Inefficiencies in the Grant Pr...
Information Technology and the Ubiquity of Bullshit
Models of science
Information Concealing Games
Why scientists chase big problems (and why it matters)
Citation metrics and the stories they tell
It's all a game: The twin fallacies of epistemic purity and the scholarly inv...
Anthropogenic evolution, externalities, and public health
Navigating science using citation networks
Ad

Recently uploaded (20)

PDF
. Radiology Case Scenariosssssssssssssss
PPTX
Application of enzymes in medicine (2).pptx
PDF
Formation of Supersonic Turbulence in the Primordial Star-forming Cloud
PPTX
Fluid dynamics vivavoce presentation of prakash
PPTX
Introduction to Fisheries Biotechnology_Lesson 1.pptx
PPTX
Pharmacology of Autonomic nervous system
PDF
Cosmic Outliers: Low-spin Halos Explain the Abundance, Compactness, and Redsh...
PPTX
2. Earth - The Living Planet Module 2ELS
DOCX
Q1_LE_Mathematics 8_Lesson 5_Week 5.docx
PPTX
TOTAL hIP ARTHROPLASTY Presentation.pptx
PDF
Warm, water-depleted rocky exoplanets with surfaceionic liquids: A proposed c...
PPTX
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
PDF
The scientific heritage No 166 (166) (2025)
PPTX
2Systematics of Living Organisms t-.pptx
PPTX
C1 cut-Methane and it's Derivatives.pptx
PDF
Placing the Near-Earth Object Impact Probability in Context
PPTX
BIOMOLECULES PPT........................
PPTX
famous lake in india and its disturibution and importance
PPTX
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
PDF
ELS_Q1_Module-11_Formation-of-Rock-Layers_v2.pdf
. Radiology Case Scenariosssssssssssssss
Application of enzymes in medicine (2).pptx
Formation of Supersonic Turbulence in the Primordial Star-forming Cloud
Fluid dynamics vivavoce presentation of prakash
Introduction to Fisheries Biotechnology_Lesson 1.pptx
Pharmacology of Autonomic nervous system
Cosmic Outliers: Low-spin Halos Explain the Abundance, Compactness, and Redsh...
2. Earth - The Living Planet Module 2ELS
Q1_LE_Mathematics 8_Lesson 5_Week 5.docx
TOTAL hIP ARTHROPLASTY Presentation.pptx
Warm, water-depleted rocky exoplanets with surfaceionic liquids: A proposed c...
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
The scientific heritage No 166 (166) (2025)
2Systematics of Living Organisms t-.pptx
C1 cut-Methane and it's Derivatives.pptx
Placing the Near-Earth Object Impact Probability in Context
BIOMOLECULES PPT........................
famous lake in india and its disturibution and importance
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
ELS_Q1_Module-11_Formation-of-Rock-Layers_v2.pdf

Proactive COVID-19 testing to mitigate spread

  • 1. COVID-19 Proactive testing to mitigate spread Carl T. Bergstrom Department of Biology University of Washington IPAM Workshop on Mathematical Models in Understanding COVID-19 Photo: Carl Bergstrom
  • 2. Analytic approximations Ted Bergstrom, UCSB Haoran Li, UCSB Stochastic network model Ryan McGee, UW with Ben Kerr, Omar Cornejo, Mark Tanaka, Julian Homberger, Hannah Williams, Alicia Zhou Photo: Carl Bergstrom
  • 3. Disclosures I have a paid consulting relationship with Color Genomics, and I will be talking about some of that work today. I have no financial interest in the production or sales of COVID tests or treatments. I do have vested interests in going places, seeing people, working at the office, eating at restaurants, drinking at the bar, playing sports, hearing live music, sending my son to school, sending my daughter to college, visiting Europe, visiting anywhere else, and photographing birds that can’t be bothered to visit Seattle. Photo: Carl Bergstrom
  • 4. A vaccine is coming But it won’t be a panacea—if it comes at all. Photo: Carl Bergstrom
  • 5. We need something else Something nimble. Photo: Carl Bergstrom
  • 6. This is a talk about testing. Photo: Carl Bergstrom
  • 7. Four roles for Covid-19 testing Individual diagnosis, clearance, surveillance, and mitigation. 1. Individual diagnosis Symptomatic patients, for treatment and peace of mind. High sensitivity and specificity desired. CC-BY-2.0 Lisa Helfert
  • 8. Four roles for Covid-19 testing Individual diagnosis, clearance, surveillance, and mitigation. 2. Clearance Verify that patients and practitioners are uninfected prior to performing a procedure. Travel? Other activities? High sensitivity needed. Specificity less essential. CC 59th Medical Wing
  • 9. Four roles for Covid-19 testing Individual diagnosis, clearance, surveillance, and mitigation. 3. Surveillance Public health officials want to track prevalence and trajectory of pandemic. Can correct for lower sensitivity and (if common) lower specificity. Chen and Ngu 2020 ProPublica
  • 10. Four roles for Covid-19 testing Individual diagnosis, clearance, surveillance, and mitigation. 4. Mitigation Find non-symptomatic cases and isolate / trace as a means of disease control. Volume is more important than sensitivity or specificity. Larremore et al. 2020 Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
  • 11. Speed is critical in all cases. 1. Individual health. Patients don’t want to wait. Treatments may depend on diagnosis. Helfert; 59th Med Wing; ProPublica; Larremore 3. Surveillance Heath officials need the latest information to make good decisions. 4. Mitigation Every day’s delay is an extra day an infected person is walking around spreading disease. 2. Clearance Tests should be point-of- care to minimize chance of becoming infectious after sampling.
  • 12. The CDC guidelines state that: Testing of all students, faculty and staff for Covid-19 before allowing campus entry (entry testing) has not been systematically studied. It is unknown if entry testing in IHEs provides any additional reduction in person-to-person transmission of the virus beyond what would be expected with implementation of other infection preventive measures (e.g., social distancing, cloth face covering, hand washing, enhanced cleaning and disinfection). Therefore, CDC does not recommend entry testing of all returning students, faculty, and staff.
  • 13. The aim of proactive (mitigation) testing: Reducing exposure-days Latent Infectious Time Test quarantine Delay d Infectious period C Results
  • 14. C # infectious days n Testing periodicity q False negative rate d Delay for results By what fraction does testing and isolation reduce exposure days relative to no testing at all?
  • 15. C # infectious days n Testing periodicity q False negative rate d Delay for results When testing periodicity is longer than infectious period, individuals will only be tested once while infectious. true positive false negativetested not tested Simplifies to Expected exposure days
  • 16. When testing periodicity is shorter than the infectious period, you get multiple chances to catch an infection. Where and C # infectious days n Testing periodicity q False negative rate d Delay for results After a bit of algebra, you can still get a nice expression for the expected exposure days.
  • 17. But some symptomatic individuals can self-isolate. We need to account for this. Time Latent Asymptomatic Exposure days u Latent Pre-sympt. Symptomatic, non-isolating Exposure days (1-u)v Latent Pre-sympt. Sympt. Self-isolating Exposure days (1-u)(1-v)
  • 18. Compare infectious days with testing to infectious days without.
  • 19. Compare infectious days with testing to infectious days without. Asymptomatic or don’t isolate Self-isolate
  • 20. Compare infectious days with testing to infectious days without. Asymptomatic or don’t isolate Self-isolate
  • 22. The real world is not so simple • Disease dynamics • Social network structure • Heterogeneity of disease trajectory, infectivity, etc. • Varying test sensitivity over time • Non-compliance with testing and isolation Photo: Carl Bergstrom
  • 23. Ryan McGee’s SEIRS+ framework Open source python-based stochastic SEIRS model with multi-level network structure, network interventions (targeted testing, social distance, contact tracing, isolation, etc.) https://github.com/ryansmcgee/seirsplus
  • 25. Testing, tracing, and isolation https://github.com/ryansmcgee/seirsplus
  • 28. Test sensitivity Kucirka et al. 2020 Ann. Int. Med. https://github.com/ryansmcgee/seirsplus
  • 29. Use case: workplace testing https://www.color.com/covid-19-outbreak-model Setting: workplaces of size 50-1000. Intervention: self-administered workplace testing via nasal swab. Network: single-layer FARZ network with 40% global transmission Outcome measure: size of epidemic resulting from one introduction
  • 33. Testing helps a lot https://www.color.com/covid-19-outbreak-model Total epidemic size
  • 35. Speed is of the essence https://www.color.com/covid-19-outbreak-model Mean fraction infected Fraction >5% Total epidemic size
  • 36. Use case: community test-trace-isolate Setting: Community of 50,000 Intervention: test-trace-isolate Network: multilayer FARZ with household, school, workplace structure. Outcome measure: change in effective R value
  • 38. Test, trace, and isolate Households of positive tests are isolated. Contacts traced in two days, and isolated along with household.
  • 39. Comparing with the analytic approximation
  • 40. Comparing with the analytic approximation
  • 44. Take-home messages Proactive testing can help control the epidemic… …but the speed of turnaround is essential. Simple models give decent approximations and allow quick exploration of speed / sensitivity / volume / cost tradeoffs. Network structure and heterogeneity matter—especially for rapid spread. Photo: Carl Bergstrom